Sandercock Brett 4
4 · RESMED INC · Filed Sep 3, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Sandercock Brett
Chief Financial Officer
Transactions
- Sale
ResMed Common Stock
2025-09-02$270.77/sh−3,000$812,310→ 87,745 total - Exercise/Conversion
ResMed Common Stock Options
2025-09-02−2,000→ 4,000 totalExercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (2,000 underlying) - Exercise/Conversion
ResMed Common Stock
2025-09-02$101.64/sh+2,000$203,280→ 90,745 total
Footnotes (2)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
- [F2]Represents date options first become exercisable. Options vest 1/3 per year.